Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,310 | 2,000 | 3,200 | 1,550 | 2,840 |
| Other current assets | 1,460 | 1,550 | 1,740 | 1,660 | 1,820 |
| TOTAL | $2,770 | $3,550 | $4,940 | $3,210 | $4,660 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3,475 | 3,395 | 3,685 | 3,635 | 3,595 |
| TOTAL | $3,475 | $3,395 | $3,685 | $3,635 | $3,595 |
| Total Assets | $6,260 | $6,950 | $8,630 | $6,850 | $8,270 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 930 | 590 | 800 | 440 | 940 |
| Accrued Expenses | 300 | 370 | 520 | 800 | 650 |
| TOTAL | $3,430 | $3,160 | $3,530 | $3,440 | $3,790 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 190 | 330 | 500 | 570 | 530 |
| TOTAL | $190 | $330 | $500 | $570 | $530 |
| Total Liabilities | $3,630 | $3,500 | $4,030 | $4,020 | $4,330 |
| Shareholders' Equity | |||||
| Common Shares | 1,160 | 940 | 910 | 800 | 790 |
| Retained earnings | -70,150 | -67,440 | -65,830 | -64,350 | -62,690 |
| Other shareholders' equity | 0 | 0 | 0 | 10 | 0 |
| TOTAL | $2,620 | $3,450 | $4,590 | $2,830 | $3,930 |
| Total Liabilities And Equity | $6,250 | $6,950 | $8,620 | $6,850 | $8,260 |